Anixa Biosciences, Inc. stock is up 37.2% since 30 days ago. The next earnings date is Jan 3, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 9 December’s closed higher than November. 100% of analysts rate it a buy.
Anixa Biosciences, Inc. develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is also developing immuno-therapy drugs against cancer.